Tarsus Pharmaceuticals (TARS) PT Raised to $50 at Barclays
Tweet
Share
E-mailGet Alerts TARS Hot Sheet
Price: $74.73 -3.05%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Tarsus Pharmaceuticals (NASDAQ: TARS) to $50.00 (from $40.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Northern Star Resources (NST:AU) (NESRF) PT Lowered to AUD19 at RBC Capital
- KEPCO (015760:KS) (KEP) PT Lowered to KRW26,000 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
